z-logo
open-access-imgOpen Access
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal Impairment
Author(s) -
James A. Dowell,
Thomas Marbury,
William B. Smith,
Tim Henkel
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00253-22
Subject(s) - cefepime , pharmacokinetics , medicine , renal function , pharmacology , impaired renal function , antibiotics , biology , microbiology and biotechnology , antibiotic resistance , imipenem

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom